Details for New Drug Application (NDA): 022184

✉ Email this page to a colleague

NDA 022184 describes LUMIGAN, which is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. There are twelve patents protecting this drug and two Paragraph IV challenges. Additional details are available on the LUMIGAN profile page.

The generic ingredient in LUMIGAN is bimatoprost. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.

Summary for 022184

Tradename:	LUMIGAN
Applicant:	Abbvie
Ingredient:	bimatoprost
Patents:	12

Pharmacology for NDA: 022184

Medical Subject Heading (MeSH) Categories for 022184

Antihypertensive Agents

Suppliers and Packaging for NDA: 022184

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LUMIGAN	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	022184	NDA	Allergan, Inc.	0023-3205	0023-3205-02	1 BOTTLE, DROPPER in 1 CARTON (0023-3205-02) / 2.5 mL in 1 BOTTLE, DROPPER
LUMIGAN	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	022184	NDA	Allergan, Inc.	0023-3205	0023-3205-03	1 BOTTLE, DROPPER in 1 CARTON (0023-3205-03) / 2.5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.01%
Approval Date:	Aug 31, 2010	TE:		RLD:	Yes
Patent:	⤷ Subscribe	Patent Expiration:	Jun 13, 2027	Product Flag?	Y	Substance Flag?	Y	Delist Request?
Patent:	⤷ Subscribe	Patent Expiration:	Mar 16, 2025	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	⤷ Subscribe	Patent Expiration:	Mar 16, 2025	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION

Expired US Patents for NDA 022184

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	LUMIGAN	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	022184-001	Aug 31, 2010	⤷ Subscribe	⤷ Subscribe
Abbvie	LUMIGAN	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	022184-001	Aug 31, 2010	⤷ Subscribe	⤷ Subscribe
Abbvie	LUMIGAN	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	022184-001	Aug 31, 2010	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.